Skip to main content
. 2021 Jun 17;11:12763. doi: 10.1038/s41598-021-91928-3

Figure 6.

Figure 6

Dual inhibition of HMGCR in TGF-β-induced epithelial cancer cells. Following microenvironment-induced phenotypic state switch in epithelial cancer cells the dual inhibition of HMGCR, by downregulation of its expression (by siRNA or Cmpd81) and its enzymatic activity (by statins) leads to reduced cholesterol levels and reduced synthesis of the mevalonate pathway’s intermediate metabolites that are required for prenylation of signaling proteins. This dual treatment regimen may also reduce the metastatic competence of emerging (micro)tumors to a greater extent than atorvastatin treatment alone19.